Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-002704
Filing Date
2018-05-23
Accepted
2018-05-23 11:55:56
Documents
56
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q biei_10q.htm 10-Q 282096
2 CERTIFICATION biei_ex311.htm EX-31.1 7658
3 CERTIFICATION biei_ex312.htm EX-31.2 7650
4 CERTIFICATION biei_ex321.htm EX-32.1 3553
5 CERTIFICATION biei_ex322.htm EX-32.2 3545
  Complete submission text file 0001477932-18-002704.txt   2369365

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT biei-20180331.xml EX-101.INS 411544
7 XBRL TAXONOMY EXTENSION SCHEMA biei-20180331.xsd EX-101.SCH 61317
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE biei-20180331_cal.xml EX-101.CAL 38928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE biei-20180331_def.xml EX-101.DEF 94314
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE biei-20180331_lab.xml EX-101.LAB 201252
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biei-20180331_pre.xml EX-101.PRE 167301
Mailing Address P.O. BOX 25 JACKSON CENTER PA 16133
Business Address P.O. BOX 25 JACKSON CENTER PA 16133 724-633-7033
PREMIER BIOMEDICAL INC (Filer) CIK: 0001515740 (see all company filings)

EIN.: 272635666 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54563 | Film No.: 18854541
SIC: 2836 Biological Products, (No Diagnostic Substances)